Developer docs
API playgroundTry for free, no card

Search company profiles

RNAgri

Full company profile

uuid0004jgv

Namestring
RNAgri
Websiteurl
rnagri.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

RNAgri is a St. Louis, Missouri-based biotechnology company founded in 2011 that develops and produces ribonucleic acid (RNA) and RNA interference (RNAi) products. The company is positioned at the intersection of molecular biology and what appears to be agricultural biotechnology, based on its name and the involvement of agtech-focused investor The Yield Lab in its 2015 funding round. RNAgri operates with a small team of 1-10 employees and is led by John Killmer as Chief Executive Officer and Patrick McLaughlin as VP of Technology and Director of Molecular Biology — a configuration that signals a tightly run, technically driven organization centered on RNA science.

The company has raised approximately $2.9 million in cumulative disclosed funding across six rounds between 2012 and 2017, drawing on a regional St. Louis investor base including BioGenerator (a regional life sciences generator that provided initial seed support), St. Louis Arch Angels, the Allen Angel Capital Education Program (AACE), and The Yield Lab. No product details, customer relationships, pricing, or commercial channels are publicly disclosed, and no patents or certifications are listed in the source material.

The company's website (rnagri.com) currently resolves to a parked/redirect page, and no commercial milestones, leadership changes, or new funding events have been recorded since the July 2017 round. The combination of a multi-year absence of observable activity, undisclosed commercial metrics, and a non-functional public web presence limits the ability to characterize current operating status or revenue generation with confidence.

Short descriptiontext

RNAgri is a St. Louis-based biotech startup founded in 2011 that develops RNA and RNAi products, operating with 1-10 employees and having raised approximately $2.9M across six funding rounds through 2017, with no disclosed commercial activity since.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSt Louis, United States
HQ citystring
St Louis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
RNA products, RNAi products, Ribonucleic acid production, Agricultural biotechnology, Molecular biology reagents
Industry1 code
PRIMARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
Product category
Agricultural Biotechnology
No data
Cost components4 values
Personnel, Operations, Technology or R&D, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

RNAgri is a biotechnology startup that produces ribonucleic acid (RNA) and RNA interference (RNAi) products. The company focuses on the manufacturing of RNA-based biological products for agricultural and life-science applications, leveraging proprietary RNA production know-how and molecular biology expertise to deliver specialty RNA reagents.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Ribonucleic acid (RNA) and RNA interference (RNAi) products
CategoryAgricultural biotechnology / RNA reagents
Description

Manufactured RNA and RNAi biological products supplied to organizations in agricultural biotechnology and life-science applications that require specialty ribonucleic acid inputs.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GreenLight Biosciences develops RNA-based products for agriculture and human health, including RNAi-based crop protection. It is a direct peer to RNAgri given the overlap in RNA manufacturing for agricultural applications.

TypeBroad incumbent
Description

Alnylam is the leading RNAi therapeutics company with approved products and a large pipeline. It is a broad incumbent peer given its dominant position in RNAi technology and manufacturing, overlapping with RNAgri's core competency.

TypeDirect peer
Description

TriLink BioTechnologies specializes in mRNA and oligonucleotide manufacturing, offering custom RNA synthesis services. It is a direct peer given its focus on commercial-scale RNA manufacturing similar to RNAgri's stated production capability.

TypeBroad incumbent
Description

Ionis is a leading RNA-targeted therapeutics company with antisense oligonucleotide (ASO) technology. It is a broad incumbent peer given its RNA chemistry and manufacturing expertise in the broader RNA therapeutics space.

TypeBroad incumbent
Description

Moderna is a leader in mRNA therapeutics and vaccines with large-scale manufacturing infrastructure. It is a broad incumbent peer given its dominant position in RNA manufacturing at scale, though its focus is therapeutic rather than agricultural.

6RNAissance Ag
TypeEmerging player
Description

RNAissance Ag is an early-stage company developing RNAi-based pest control solutions for agriculture. It is an emerging player peer directly competing with RNAgri in the agricultural RNAi niche with a similar science-led startup profile.

TypeBroad incumbent
Description

Agilent provides molecular biology tools, including oligonucleotide synthesis and genomics instruments. It is a broad incumbent peer given its overlap with RNAgri's RNA production and molecular biology expertise, though at a vastly larger scale.

TypeBroad incumbent
Description

BioNTech is a major mRNA therapeutics and immunotherapy company with large-scale RNA manufacturing. It is a broad incumbent peer given its leadership in RNA-based product development and manufacturing technology.

TypeRegional player
Description

Syngenta is a global agribusiness with R&D into RNAi-based crop protection technologies. It is a regional peer in that it operates globally as a major agricultural inputs player, overlapping with RNAgri's likely agricultural RNAi focus as both a potential customer and competitor.

TypeOthers
Description

BioGenerator is a St. Louis-based biotech startup generator and investor that has backed RNAgri. It is an "other" peer given its role as an investor/incubator rather than a direct competitor, but its portfolio overlaps with RNAgri's ecosystem and is thematically related.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RNAgri

Agricultural Biotechnologyrnagri.com

RNAgri is a St. Louis-based biotech startup founded in 2011 that develops RNA and RNAi products, operating with 1-10 employees and having raised approximately $2.9M across six funding rounds through 2017, with no disclosed commercial activity since.

What RNAgri does

RNAgri is a St. Louis, Missouri-based biotechnology company founded in 2011 that develops and produces ribonucleic acid (RNA) and RNA interference (RNAi) products. The company is positioned at the intersection of molecular biology and what appears to be agricultural biotechnology, based on its name and the involvement of agtech-focused investor The Yield Lab in its 2015 funding round. RNAgri operates with a small team of 1-10 employees and is led by John Killmer as Chief Executive Officer and Patrick McLaughlin as VP of Technology and Director of Molecular Biology — a configuration that signals a tightly run, technically driven organization centered on RNA science.

The company has raised approximately $2.9 million in cumulative disclosed funding across six rounds between 2012 and 2017, drawing on a regional St. Louis investor base including BioGenerator (a regional life sciences generator that provided initial seed support), St. Louis Arch Angels, the Allen Angel Capital Education Program (AACE), and The Yield Lab. No product details, customer relationships, pricing, or commercial channels are publicly disclosed, and no patents or certifications are listed in the source material.

The company's website (rnagri.com) currently resolves to a parked/redirect page, and no commercial milestones, leadership changes, or new funding events have been recorded since the July 2017 round. The combination of a multi-year absence of observable activity, undisclosed commercial metrics, and a non-functional public web presence limits the ability to characterize current operating status or revenue generation with confidence.

RNAgri firmographics

Firmographics
Name
RNAgri
Website
https://rnagri.com
Company type
Private
Founded year
2011
Headcount range
1–10 employees
Short description
RNAgri is a St. Louis-based biotech startup founded in 2011 that develops RNA and RNAi products, operating with 1-10 employees and having raised approximately $2.9M across six funding rounds through 2017, with no disclosed commercial activity since.
Ownership category
akta.pro rank

RNAgri industry classification

Industry
Product category
Agricultural Biotechnology
akta.pro industry
PRIMARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

Keywords

  • RNA products
  • RNAi products
  • Ribonucleic acid production
  • Agricultural biotechnology
  • Molecular biology reagents

Where RNAgri is headquartered

Location

Headquarters

HQ city
St Louis
HQ country
United States
HQ region
North America

Markets served

RNAgri business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain

RNAgri product offering

Product offering

Core offering

RNAgri is a biotechnology startup that produces ribonucleic acid (RNA) and RNA interference (RNAi) products. The company focuses on the manufacturing of RNA-based biological products for agricultural and life-science applications, leveraging proprietary RNA production know-how and molecular biology expertise to deliver specialty RNA reagents.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ribonucleic acid (RNA) and RNA interference (RNAi) products Manufactured RNA and RNAi biological products supplied to organizations in agricultural biotechnology and life-science applications that require specialty ribonucleic acid inputs.

Companies that use RNAgri

Customer profile

Ideal customer profiles1 record

RNAgri technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

RNAgri partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights1 record

RNAgri competitors and assessment

Company assessment

Direct peers

  • GreenLight Biosciences: GreenLight Biosciences develops RNA-based products for agriculture and human health, including RNAi-based crop protection. It is a direct peer to RNAgri given the overlap in RNA manufacturing for agricultural applications.
  • TriLink BioTechnologies: TriLink BioTechnologies specializes in mRNA and oligonucleotide manufacturing, offering custom RNA synthesis services. It is a direct peer given its focus on commercial-scale RNA manufacturing similar to RNAgri's stated production capability.

Broad incumbents

  • Alnylam Pharmaceuticals: Alnylam is the leading RNAi therapeutics company with approved products and a large pipeline. It is a broad incumbent peer given its dominant position in RNAi technology and manufacturing, overlapping with RNAgri's core competency.
  • Ionis Pharmaceuticals: Ionis is a leading RNA-targeted therapeutics company with antisense oligonucleotide (ASO) technology. It is a broad incumbent peer given its RNA chemistry and manufacturing expertise in the broader RNA therapeutics space.
  • Moderna: Moderna is a leader in mRNA therapeutics and vaccines with large-scale manufacturing infrastructure. It is a broad incumbent peer given its dominant position in RNA manufacturing at scale, though its focus is therapeutic rather than agricultural.
  • Agilent Technologies: Agilent provides molecular biology tools, including oligonucleotide synthesis and genomics instruments. It is a broad incumbent peer given its overlap with RNAgri's RNA production and molecular biology expertise, though at a vastly larger scale.
  • BioNTech: BioNTech is a major mRNA therapeutics and immunotherapy company with large-scale RNA manufacturing. It is a broad incumbent peer given its leadership in RNA-based product development and manufacturing technology.

Emerging players

  • RNAissance Ag: RNAissance Ag is an early-stage company developing RNAi-based pest control solutions for agriculture. It is an emerging player peer directly competing with RNAgri in the agricultural RNAi niche with a similar science-led startup profile.

Regional players

  • Syngenta: Syngenta is a global agribusiness with R&D into RNAi-based crop protection technologies. It is a regional peer in that it operates globally as a major agricultural inputs player, overlapping with RNAgri's likely agricultural RNAi focus as both a potential customer and competitor.

Others

  • BioGenerator: BioGenerator is a St. Louis-based biotech startup generator and investor that has backed RNAgri. It is an "other" peer given its role as an investor/incubator rather than a direct competitor, but its portfolio overlaps with RNAgri's ecosystem and is thematically related.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights5 records

Customer concentration

RNAgri financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RNAgri leadership team

Management profile

Number of profiles

Profiles2 records

RNAgri funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RNAgri M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RNAgri

What does RNAgri do?

RNAgri is a biotechnology startup that produces ribonucleic acid (RNA) and RNA interference (RNAi) products. The company focuses on the manufacturing of RNA-based biological products for agricultural and life-science applications, leveraging proprietary RNA production know-how and molecular biology expertise to deliver specialty RNA reagents.

When was RNAgri founded?

RNAgri was founded in 2011. It employs 1 to 10 people.

Where is RNAgri based?

RNAgri is headquartered in St Louis, United States, in the North America region.

Who are RNAgri's main competitors?

Direct peers on record are GreenLight Biosciences and TriLink BioTechnologies. Broad incumbents are Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Moderna, Agilent Technologies and BioNTech. RNAissance Ag is listed as an emerging player. Syngenta is listed as a regional player. BioGenerator is listed as an others.

Does RNAgri have an API?

No public API is recorded for RNAgri.

What industry is RNAgri in?

RNAgri's product category is Agricultural Biotechnology. Its primary akta.pro industry code is HLAGANAE, Transcriptomics & Gene Expression Profiling Services.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals